Sigyn Therapeutics, Inc. Annual Depreciation in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sigyn Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2023.
  • Sigyn Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $1.36K, a 20.6% decline year-over-year.
  • Sigyn Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $5.86K, a 14.6% decline year-over-year.
  • Sigyn Therapeutics, Inc. annual Depreciation for 2023 was $6.76K, a 1.43% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Depreciation for 2022 was $6.85K, a 133% increase from 2021.
  • Sigyn Therapeutics, Inc. annual Depreciation for 2021 was $2.95K, a 751% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.76K -$98 -1.43% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $6.85K +$3.91K +133% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $2.95K +$2.6K +751% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $346 -$12.1K -97.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $12.4K -$278 -2.19% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-30
2018 $12.7K -$1.01K -7.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $13.7K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2015 $1.16K Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.